Transplant stories

Smart Cells has now released more samples for clinical use than any other private storage company in the UK with a 100 per cent success rate. These have been used by patients all around the world to treat a range of conditions including Cerebral Palsy, Thalassemia, Leukaemia, and HSV Encephalitis.

This significant milestone for the industry highlights the advances being made in stem cell research, a service many parents-to-be are not yet aware of. Smart Cells is working to change that – and help more parents protect their children’s wellbeing and future.

Now part of the FamiCord Group, we empowers our clients to explore the potential of stem cell therapy for various disorders. We remain at the forefront of stem cell therapy, providing its clients with access to these innovative treatments. Explore the diverse range of conditions successfully treated with stem cells to understand how FamiCord continues to make a difference.